Achieving HCV Elimination in the United States: Progress and Next Steps

This interactive video module provides in-depth expert perspectives on critical barriers impeding the diagnosis, treatment, and cure of HCV infection among persons who inject drugs along with an analysis of critical strategies for overcoming these challenges to address both HCV and other important healthcare needs of this vulnerable population.

Mark S. Sulkowski, MD
Program Director Arthur Kim, MD Christian B. Ramers, MD, MPH Jeannette M. Tetrault, MD, FACP, FASAM Physicians: maximum of 1.75 AMA PRA Category 1 Credits™ Registered Nurses: 1.7 Nursing contact hours Pharmacists: 1.75 contact hours (0.175 CEUs) Released: April 2, 2019 Expired: April 1, 2020

People who inject drugs continue to be a marginalized population in the United States with substantial unmet medical needs, including bearing a majority proportion of the burden of HCV infection. What models of care can we implement to improve linkage to care and treatment outcomes?

Alain H. Litwin, MD Released: June 14, 2019

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provide insights on evidence-based interventions to improve the HCV care cascade for people who inject drugs, including important strategies for overcoming barriers to effective HCV prevention, screening, linkage to care, treatment, and cure in this population, including the critical role of HCV treatment as prevention.

Jason Grebely, BSc, PhD Released: June 21, 2019

Listen to downloadable audio from a live Webinar in which CCO’s expert faculty provides insights on emerging models of HCV care that have the potential to expand diagnosis, treatment, and cure for people who inject drugs, an essential population for reaching the goals of HCV elimination.

Stacey Trooskin, MD, PhD Released: July 10, 2019

This downloadable slideset provides an in-depth review of strategies for overcoming barriers to the elimination of HCV infection among persons who inject drugs.

Arthur Kim, MD Christian B. Ramers, MD, MPH Jeannette M. Tetrault, MD, FACP, FASAM Released: April 2, 2019

This downloadable slideset provides an overview of the tools now available to help providers overcome barriers across the HCV care cascade for people who inject drugs, including simplified HCV management strategies and evidence-based interventions to improve linkage to care.

Jason Grebely, BSc, PhD Released: June 18, 2019

This downloadable slideset provides an examination of models of HCV care that aim to help overcome barriers to treatment and cure for people who inject drugs, including intensified linkage to care and on-treatment support strategies.

Stacey Trooskin, MD, PhD Released: June 27, 2019